GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients Data Published From Phase 2 Open-Label Study of GEO-CM04S1 ATLANTA, GA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing...

Physicians for Informed Consent Updates Its Information Statement About Vaccines and Immunocompromised Schoolchildren, Includes Data on COVID-19 Vaccines NEWPORT BEACH, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, has released an update to...

Fifth Update of ACR COVID-19 Vaccine Guidance Supports Fourth Doses for High-Risk Rheumatic Disease Patients Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and...

Public Health Officials Know: Recently Vaccinated Individuals Spread Disease Washington, D.C., March 3, 2015 (GLOBE NEWSWIRE) -- Physicians and public health officials know that recently vaccinated individuals can spread disease and that contact with the immunocompromised can...

Inergetics Receives $112,500 Purchase Order for Resurgex Select(TM) From New Marketlink Pharmaceutical Corporation PARAMUS, N.J., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Inergetics, Inc. (OTCBB:NRTI), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that...